Contact
Please use this form to send email to PR contact of this press release:
TCR² Therapeutics Announces Immuno-Oncology Pioneer Dr. Axel Hoos Joins its Board of Directors
TO:
Please use this form to send email to PR contact of this press release:
TCR² Therapeutics Announces Immuno-Oncology Pioneer Dr. Axel Hoos Joins its Board of Directors
TO: